Bryan Garnier

Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.

Mahaut Arnaud ... (+3)
  • Mahaut Arnaud
  • Paul de Froment
  • Thomas Mordelle

Loop Industries: Q3 results, set to move forward in India

This morning, Loop Industries published Q3 2024-25 (3-months ended Nov. 2024) results, aligned with expectations based on the company's current phase of deployment. Q3 2024-25 sales came in at USD52k (doubling YoY, vs. USD26k in Q3 2023-24) coming from ongoing contracts with customers. Although sup

Clement Genelot
  • Clement Genelot

Jeronimo Martins: LfL already back to growth

With Q4 returning to LfL growth at both the Biedronka and group levels, Jeronimo Martins topped the css and our expectations. In a still unhelpful albeit easing environment, the scenario behind our upgrade to Buy seems to be taking shape, and we continue to foresee a clear rerating path from 16x to

Antoine Lebourgeois
  • Antoine Lebourgeois

Ekinops: pivotal 2025 in sight for recovery

Ekinops reported Q4 2024 revenues of EUR29.8m, down 2% yoy and down 2% qoq, missing expectations (EUR32.8m BGe, EUR32.9m css) as sequential softness continued within the EUR28–30m range persisting since Q3 2023. The 2025 outlook remains "cautiously optimistic", with anticipated growth in both the A

Bruno Bulic ... (+2)
  • Bruno Bulic
  • Healthcare Team

Transfer of Medios coverage

Following the transfer of coverage of Medios to Bruno Bulic, we have placed our Price Target under review.

Clement Genelot
  • Clement Genelot

HelloFresh: model update

Ahead of the Q4 release on 13th March, we have updated our FY 2024-25 estimates to take into account a stronger USD tailwind, lower CAPEX and a higher WCR contribution. PT unchanged at EUR10.

Gregory Ramirez
  • Gregory Ramirez

LECTRA BUY | EUR45 Good resistance Chinese lockdowns; strong orde...

º Q2 results were slightly below expectations, but remained decent despite lockdowns in China New system orders hold up well thanks to automotive Company guidance for 2022 has been tightened toward its mid-point

Thibault Morel
  • Thibault Morel

HMS NETWORKS: HMS Networks 2Q22 results above expectations | CONVICTIO...

HMS NETWORKS - CONVICTION BUY | SEK500 HMS Networks 2Q22 results above expectations 2Q22 sales and new orders above expectations Positive surprise on 2Q22 profitability

Cedric Rossi
  • Cedric Rossi

HUGO BOSS: Successful execution and healthy geo mix lead to raised FY2...

HUGO BOSS - NEUTRAL | EUR68 vs. EUR64 Successful execution and healthy geo mix lead to raised FY22 guidance Strong sales and EBIT beat in Q2 driven by execution… … and low exposure to China’s lockdowns FY22 sales and EBIT guidance revised upwards and we increase our FY22-23 estimates by 7%

Clement Genelot
  • Clement Genelot

ROCHE BOBOIS: Q4 topping expectations with good H1 2022 prospects

ROCHE BOBOIS: Q4 topping expectations with good H1 2022 prospects

Victor Floc’h
  • Victor Floc’h

ONCODESIGN (CORPORATE, TP EUR15) | R&D collaboration signed with TiumB...

ONCODESIGN (CORPORATE, TP EUR15) | R&D collaboration signed with TiumBio in fibrosis

ResearchPool Subscriptions

Get the most out of your insights

Get in touch